A novel CFHR5 fusion protein causes C3 glomerulopathy in a family without Cypriot ancestry

scientific article published on 25 September 2013

A novel CFHR5 fusion protein causes C3 glomerulopathy in a family without Cypriot ancestry is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1038/KI.2013.348
P932PMC publication ID3789233
P698PubMed publication ID24067434
P5875ResearchGate publication ID257073606

P50authorCharlie TomsonQ51105169
Matthew C PickeringQ55692581
P2093author name stringH Terence Cook
Talat H Malik
Nicholas Medjeral-Thomas
Mitali P Patel
Tibor Toth
P2860cites workIdentification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritisQ24615589
Dimerization of complement factor H-related proteins modulates complement activation in vivoQ27676814
Factor H family proteins: on complement, microbes and human diseasesQ33345389
Translational mini-review series on complement factor H: renal diseases associated with complement factor H: novel insights from humans and animals.Q33378236
Location and structure of the human FHR-5 geneQ34131162
Genome-wide association study identifies susceptibility loci for IgA nephropathyQ34170453
Familial C3 glomerulopathy associated with CFHR5 mutations: clinical characteristics of 91 patients in 16 pedigreesQ35030648
A hybrid CFHR3-1 gene causes familial C3 glomerulopathy.Q36050943
C3 glomerulopathy-associated CFHR1 mutation alters FHR oligomerization and complement regulationQ36891110
Recent insights into C3 glomerulopathyQ38088187
P433issue4
P407language of work or nameEnglishQ1860
P304page(s)933-937
P577publication date2013-09-25
P1433published inKidney InternationalQ6404823
P1476titleA novel CFHR5 fusion protein causes C3 glomerulopathy in a family without Cypriot ancestry
P478volume85

Reverse relations

cites work (P2860)
Q37682273American Society of Nephrology clinical pathological conference
Q51730313An Engineered Complement Factor H Construct for Treatment of C3 Glomerulopathy.
Q39207807C3 glomerulopathy
Q52339140C3 glomerulopathy in cystic fibrosis: a case report.
Q37348685C3 glomerulopathy: consensus report
Q40136434Circulating complement factor H-related proteins 1 and 5 correlate with disease activity in IgA nephropathy
Q34455125Defining the complement biomarker profile of C3 glomerulopathy
Q37017177Distinct roles for the complement regulators factor H and Crry in protection of the kidney from injury.
Q47111288Factor H-Related (FHR)-1 and FHR-2 Form Homo- and Heterodimers, while FHR-5 Circulates Only As Homodimer in Human Plasma
Q38275117Histopathology of MPGN and C3 glomerulopathies
Q38549182Kidney Disease Caused by Dysregulation of the Complement Alternative Pathway: An Etiologic Approach.
Q64039347Nephritic Factors: An Overview of Classification, Diagnostic Tools and Clinical Associations
Q92030175Novel CFHR2-CFHR1 Hybrid in C3 Glomerulopathy Identified by Genomic Structural Variation Analysis
Q35567846Pathogenesis of glomerular haematuria.
Q55385450Progressive IgA Nephropathy Is Associated With Low Circulating Mannan-Binding Lectin-Associated Serine Protease-3 (MASP-3) and Increased Glomerular Factor H-Related Protein-5 (FHR5) Deposition.
Q26741542Reclassification of membranoproliferative glomerulonephritis: Identification of a new GN: C3GN
Q58803464Reference Intervals of Factor H and Factor H-Related Proteins in Healthy Children
Q64044064Self-Damage Caused by Dysregulation of the Complement Alternative Pathway: Relevance of the Factor H Protein Family
Q37032691The Genetics of Ultra-Rare Renal Disease
Q38991052The complement factor H-related proteins
Q40744602Update on C3 glomerulopathy.

Search more.